Ignite Creation Date:
2024-05-06 @ 3:01 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04500548
Status:
WITHDRAWN
Last Update Posted:
2022-09-10
First Post:
2020-08-04
Brief Title:
Testing the Combination of Two Immunotherapy Drugs Nivolumab and Ipilimumab in Children Adolescent and Young Adult Patients With RelapsedRefractory Cancers That Have an Increased Number of Genetic Changes The 3CI Study
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-04
First Submit QC Date:
August 4 2020
Study First Post Date:
2020-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-09
Last Update Post Date:
2022-09-10
Last Update Post Date Type:
ACTUAL